The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118834952 11883495 2 F 20160825 20151231 20160830 EXP PHHY2014BR146269 NOVARTIS 0.00 M Y 90.00000 KG 20160830 MD BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118834952 11883495 1 PS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 20 MG, QMO 21008 20 MG SUSPENSION /month
118834952 11883495 2 C PURAN LEVOTHYROXINE SODIUM 1 Oral 1 DF, QD 0 1 DF QD
118834952 11883495 3 C GLIFAGE XR METFORMIN HYDROCHLORIDE 1 Oral 1 DF, QHS 0 1 DF EXTENDED RELEASE TABLET
118834952 11883495 4 C CAPTOPRIL. CAPTOPRIL 1 Oral 3 DF, QD Y 0 3 DF TABLET QD
118834952 11883495 5 C CAPTOPRIL. CAPTOPRIL 1 Unknown 30 MG, QHS Y 0 30 MG TABLET
118834952 11883495 6 C SIMVASTATIN. SIMVASTATIN 1 Oral 1 DF, QHS Y 0 1 DF TABLET
118834952 11883495 7 C PREDNISONE. PREDNISONE 1 Oral 1 DF, QD 0 1 DF TABLET QD
118834952 11883495 8 C AMITRIPTYLINE AMITRIPTYLINE 1 Oral 1 DF, QD 0 1 DF TABLET QD
118834952 11883495 9 C AMITRIPTYLINE AMITRIPTYLINE 1 0 TABLET
118834952 11883495 10 C TOFRANIL IMIPRAMINE HYDROCHLORIDE 1 Oral 35 MG (1 TABLET OF 25 MG AND 1 TABLET OF 10 MG), QHS 0 35 MG TABLET
118834952 11883495 11 C LOSARTAN. LOSARTAN 1 Oral 2 DF, BID 0 2 DF BID
118834952 11883495 12 C OMEPRAZOLE. OMEPRAZOLE 1 Oral 2 DF, QD 0 2 DF QD
118834952 11883495 13 C DEPOSTERON 2 Intramuscular 1 DF, QD 0 1 DF INJECTION QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118834952 11883495 1 Acromegaly
118834952 11883495 2 Thyroid disorder
118834952 11883495 3 Diabetes mellitus
118834952 11883495 4 Blood pressure increased
118834952 11883495 6 Blood cholesterol increased
118834952 11883495 7 Acromegaly
118834952 11883495 8 Anxiety
118834952 11883495 9 Depression
118834952 11883495 10 Depression
118834952 11883495 11 Blood pressure increased
118834952 11883495 12 Product used for unknown indication
118834952 11883495 13 Blood testosterone abnormal

Outcome of event

Event ID CASEID OUTC COD
118834952 11883495 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
118834952 11883495 Blood glucose decreased
118834952 11883495 Cholelithiasis
118834952 11883495 Depression
118834952 11883495 Emotional disorder
118834952 11883495 Hormone level abnormal
118834952 11883495 Injection site pain
118834952 11883495 Memory impairment
118834952 11883495 Pneumonia
118834952 11883495 Sexual dysfunction
118834952 11883495 Sluggishness
118834952 11883495 Somnolence
118834952 11883495 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
118834952 11883495 1 2011 0